RSLS News and Press, ReShape Lifesciences Inc. From 12/13/23

2023-12-13 09:58:50 ET DENVER, Colo., Dec. 13, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Shattuck Labs Inc (NASDAQ: STTK), Reshape Lifesciences Inc (NASDAQ: RSLS), SciSparc Ltd (NASDAQ: SPRC), C4 Th...

2023-12-13 08:20:13 ET DENVER, Colo., Dec 13, 2023 ( www.247marketnews.com )- ReShape Lifesciences (NASDAQ: RSLS) stated, this morning, that the U.S. Food and Drug Administration (FDA) granted PMA supplement approval its next generation, enhanced Lap-Band 2.0 FLEX, and the Company is in...

2023-12-13 06:46:06 ET More on ReShape Lifesciences ReShape Lifesciences Inc. (RSLS) Q3 2023 Earnings Call Transcript Johnson & Johnson sees GLP-1 impact on weight loss surgeries Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earni...

FLEX Technology Designed to Improve the Patient Experience Company Initiating U.S. Product Launch IRVINE, Calif., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions ...

IRVINE, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences, Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, announced today that it has entered into a warrant exercise agreement with an existing accredited investor to exercis...

2023-11-10 09:34:05 ET ReShape Lifesciences Inc. (RSLS) Q3 2023 Earnings Conference Call November 08, 2023 05:00 PM ET Company Participants Michael Miller - Rx Communications Paul Hickey - President & Chief Executive Officer Caroline Apovian - Member-ReShape ...

Third Quarter Core Operating Expenses Reduced 37% Compared to Third Quarter of 2022 Cost Reduction Plan To Reduce Operating Expenses In 2024 by Over 40% Compared to 2023 Conference Call to be Held at 5:00 pm ET Today IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Re...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

ReShape Lifesciences Inc. (RSLS) is expected to report for Q2 2024

IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the third quarter ended September 30, 2023, including...